Novonesis Revenue

In the year 2024, Novonesis had annual revenue of 3.83B EUR with 59.58% growth. Novonesis had revenue of 1.00B in the quarter ending December 31, 2024, a decrease of -78.26%.

Revenue

3.83B EUR

Revenue Growth

+59.58%

P/S Ratio

7.35

Revenue / Employee

362.27K EUR

Employees

10,582

Market Cap

29.18B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.83B	1.43B	59.58%
Dec 31, 2023	2.40B	-15.15B	-86.31%
Dec 31, 2022	17.55B	2.60B	17.40%
Dec 31, 2021	14.95B	939.00M	6.70%
Dec 31, 2020	14.01B	-362.00M	-2.52%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
The Monarch Cement Company	268.05M
Rubber Leaf	6.93M
Cardinal Ethanol, LLC	350.34M
Venator Materials	1.56B
Verde Resources	216.80K
Webco Industries	575.71M

Revenue Rankings

Novonesis News

22 days ago - Novo Nordisk Stakeholder Reports $9 Billion In Income Due To Robust Weight Loss Drug Sales - Benzinga
22 days ago - Tariffs create uncertainty and pause investment, says Novonesis CEO - CNBC
2 months ago - Novonesis A/S (NVZMF) Q4 2024 Earnings Call Transcript - Seeking Alpha
2 months ago - Novonesis: Still Too Expensive - Seeking Alpha
3 months ago - Exciting prospects in bioenergy and functional foods, Novonesis CEO says - CNBC
5 months ago - Top 3 global stocks poised for 40% gains by 2025 - Invezz
5 months ago - Novonesis A/S (NVZMF) Q3 2024 Earnings Call Transcript - Seeking Alpha
5 months ago - Novonesis: Underperformance In Price, But Now I'm Buying (Rating Upgrade) - Seeking Alpha

More News